1. Home
  2. MGY vs LGND Comparison

MGY vs LGND Comparison

Compare MGY & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnolia Oil & Gas Corporation

MGY

Magnolia Oil & Gas Corporation

HOLD

Current Price

$23.74

Market Cap

4.0B

Sector

Energy

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$205.70

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGY
LGND
Founded
2017
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.9B
IPO Year
2017
1992

Fundamental Metrics

Financial Performance
Metric
MGY
LGND
Price
$23.74
$205.70
Analyst Decision
Buy
Strong Buy
Analyst Count
14
6
Target Price
$26.00
$243.50
AVG Volume (30 Days)
2.1M
210.9K
Earning Date
02-05-2026
02-26-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
0.76
EPS
1.80
2.49
Revenue
$1,320,826,000.00
$251,233,000.00
Revenue This Year
$1.00
$47.71
Revenue Next Year
$1.20
$9.77
P/E Ratio
$13.19
$80.11
Revenue Growth
0.68
64.83
52 Week Low
$19.09
$93.58
52 Week High
$26.47
$212.49

Technical Indicators

Market Signals
Indicator
MGY
LGND
Relative Strength Index (RSI) 65.25 59.66
Support Level $22.18 $188.13
Resistance Level $23.33 $199.35
Average True Range (ATR) 0.68 9.00
MACD 0.21 0.55
Stochastic Oscillator 95.40 87.20

Price Performance

Historical Comparison
MGY
LGND

About MGY Magnolia Oil & Gas Corporation

Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: